Sigurdur Olafsson

Active Investor

President and CEO at Keenova

New Jersey

Sigurdur Olafsson, President and CEO at Keenova is an active investor based in New Jersey. This profile covers what Sigurdur Olafsson backs, at which stage, and how founders can reach out in 2026.

Mr. Sigurdur O. Olafsson has been President, Chief Executive Officer and a director since June 2022. He is a serves as President & Chief Executive Officer at Keenova. He is an Angel Indivisual. Mr. Olafsson has almost 30 years of diverse pharmaceutical experience across branded and generic drugs. Before joining Mallinckrodt, Mr. Olafsson served as chief executive officer of Hikma Pharmaceuticals plc from February 2018 to June 2022. Prior to Hikma, Mr. Olafsson served as president and chief executive officer of the Global Generic Medicines Group of Teva Pharmaceuticals, from July 2014 to January 2017. Before that, he was president of Actavis plc (Watson) (from September 2010 to June 2014) and president and chief executive officer of the Actavis Group (from October 2003 to August 2010), which develop, manufacture and distribute branded, generic and biosimilar products. Mr. Olafsson has also held a number of leadership positions in Pfizer's Global R&D organization in the U.K. and U.S., focused on branded drug development, and served as head of drug development for Omega Farma in Iceland. Mr. Olafsson has previously served as a director on the boards of Hikma (from 2018 to 2022) and Pfenex Inc. (from 2017 to 2019). Mr. Olafsson holds a MS in pharmacy (Cand Pharm) from the University of Iceland, Reykjavik.

Investor type: Angel
Stages: Early Stage Venture
Invests in: Healthcare & BiotechBiotech & Pharma
Location: New Jersey
Typical check: $500K
Past investments: 2

Notable investments

SmittenPfenex Inc

How to reach Sigurdur Olafsson

Angels and operators like Sigurdur Olafsson reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Sigurdur Olafsson invest in?

Sigurdur Olafsson invests in Healthcare & Biotech and Biotech & Pharma, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.